917
CONCLUSION: The results suggest that olanzapine may be useful in treating patients with clozapine-induced granulocytopenia without the risk of recurrence of hematologic side effects.
 patients with clozapine-induced granulocytopenia: Subject; without the risk of recurrence of hematologic side effects: Effect; olanzapine: Treatment; olanzapine: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 patients with clozapine-induced granulocytopenia: Subject; without the risk of recurrence of hematologic side effects: Effect; olanzapine: Treatment; olanzapine: Treatment.Drug